These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 11038688)
1. [Engineering antibody: from laboratory to clinic]. Xiao C; Zhu X Sheng Li Ke Xue Jin Zhan; 1997 Oct; 28(4):341-4. PubMed ID: 11038688 [No Abstract] [Full Text] [Related]
4. Response to Ivarie: Competitive bioreactor hens on the horizon. Etches RJ Trends Biotechnol; 2006 Mar; 24(3):101-2. PubMed ID: 16448712 [No Abstract] [Full Text] [Related]
5. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway. Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794 [TBL] [Abstract][Full Text] [Related]
6. Production of target-specific recombinant human polyclonal antibodies in mammalian cells. Wiberg FC; Rasmussen SK; Frandsen TP; Rasmussen LK; Tengbjerg K; Coljee VW; Sharon J; Yang CY; Bregenholt S; Nielsen LS; Haurum JS; Tolstrup AB Biotechnol Bioeng; 2006 Jun; 94(2):396-405. PubMed ID: 16596663 [TBL] [Abstract][Full Text] [Related]
7. Recombinant bispecific antibodies for cellular cancer immunotherapy. Müller D; Kontermann RE Curr Opin Mol Ther; 2007 Aug; 9(4):319-26. PubMed ID: 17694444 [TBL] [Abstract][Full Text] [Related]
8. Recombinant bispecific antibodies for cancer therapy. Kontermann RE Acta Pharmacol Sin; 2005 Jan; 26(1):1-9. PubMed ID: 15659107 [TBL] [Abstract][Full Text] [Related]
9. Competitive bioreactor hens on the horizon. Ivarie R Trends Biotechnol; 2006 Mar; 24(3):99-101. PubMed ID: 16445998 [TBL] [Abstract][Full Text] [Related]
17. Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design. Deyev SM; Lebedenko EN Bioessays; 2008 Sep; 30(9):904-18. PubMed ID: 18693269 [TBL] [Abstract][Full Text] [Related]
18. The assembly of single domain antibodies into bispecific decavalent molecules. Stone E; Hirama T; Tanha J; Tong-Sevinc H; Li S; MacKenzie CR; Zhang J J Immunol Methods; 2007 Jan; 318(1-2):88-94. PubMed ID: 17141798 [TBL] [Abstract][Full Text] [Related]
19. Display of a functional hetero-oligomeric catalytic antibody on the yeast cell surface. Lin Y; Tsumuraya T; Wakabayashi T; Shiraga S; Fujii I; Kondo A; Ueda M Appl Microbiol Biotechnol; 2003 Aug; 62(2-3):226-32. PubMed ID: 12883868 [TBL] [Abstract][Full Text] [Related]
20. Engineering mammalian cell factories for improved recombinant monoclonal antibody production: lessons from nature? Dinnis DM; James DC Biotechnol Bioeng; 2005 Jul; 91(2):180-9. PubMed ID: 15880827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]